CA 125 II ASSAY FOR THE BAYER ADVIA INTEGRATED MODULE SYSTEM

Test, Epithelial Ovarian Tumor-associated Antigen (ca125)

BAYER DIAGNOSTICS CORP.

The following data is part of a premarket notification filed by Bayer Diagnostics Corp. with the FDA for Ca 125 Ii Assay For The Bayer Advia Integrated Module System.

Pre-market Notification Details

Device IDK022329
510k NumberK022329
Device Name:CA 125 II ASSAY FOR THE BAYER ADVIA INTEGRATED MODULE SYSTEM
ClassificationTest, Epithelial Ovarian Tumor-associated Antigen (ca125)
Applicant BAYER DIAGNOSTICS CORP. 511 BENEDICT AVE. Tarrytown,  NY  10591 -5097
ContactKenneth T Edds
CorrespondentKenneth T Edds
BAYER DIAGNOSTICS CORP. 511 BENEDICT AVE. Tarrytown,  NY  10591 -5097
Product CodeLTK  
CFR Regulation Number866.6010 [🔎]
DecisionSubstantially Equivalent (SESE)
TypeTraditional
3rd Party ReviewedNo
Combination ProductNo
Date Received2002-07-18
Decision Date2002-11-27
Summary:summary

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.